(S)-(6-氧代哌啶-3-基)氨基甲酸叔丁酯结构式
|
常用名 | (S)-(6-氧代哌啶-3-基)氨基甲酸叔丁酯 | 英文名 | (S)-Tert-butyl (6-oxopiperidin-3-yl)carbamate |
|---|---|---|---|---|
| CAS号 | 172913-96-1 | 分子量 | 214.26200 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C10H18N2O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | (R)-6-氧代哌啶-3-氨基甲酸叔丁酯 |
|---|---|
| 英文名 | (R)-Tert-Butyl 6-oxopiperidin-3-ylcarbamate |
| 英文别名 | 更多 |
| 分子式 | C10H18N2O3 |
|---|---|
| 分子量 | 214.26200 |
| 精确质量 | 214.13200 |
| PSA | 67.43000 |
| LogP | 1.50940 |
| 储存条件 | 2-8°C,干燥,密封 |
| 危害码 (欧洲) | Xi |
|---|
|
~%
(S)-(6-氧代哌啶-3-基... 172913-96-1 |
| 文献:GLENMARK PHARMACEUTICALS LIMITED Patent: WO2004/22536 A1, 2004 ; Location in patent: Page 52-53 ; WO 2004/022536 A1 |
|
~%
(S)-(6-氧代哌啶-3-基... 172913-96-1 |
| 文献:Langlois, Nicole Tetrahedron Letters, 2002 , vol. 43, # 52 p. 9531 - 9533 |
|
~%
(S)-(6-氧代哌啶-3-基... 172913-96-1 |
| 文献:Langlois, Nicole Tetrahedron Letters, 2002 , vol. 43, # 52 p. 9531 - 9533 |
|
~%
(S)-(6-氧代哌啶-3-基... 172913-96-1 |
| 文献:Bellis, Evagelos; Markidis, Theodoros; Kokotos, George Synthesis, 2002 , # 10 p. 1359 - 1364 |
|
~%
(S)-(6-氧代哌啶-3-基... 172913-96-1 |
| 文献:Bellis, Evagelos; Markidis, Theodoros; Kokotos, George Synthesis, 2002 , # 10 p. 1359 - 1364 |
|
~81%
(S)-(6-氧代哌啶-3-基... 172913-96-1 |
| 文献:Panday, Sharad Kumar; Langlois, Nicole Tetrahedron Letters, 1995 , vol. 36, # 45 p. 8205 - 8208 |
|
~%
(S)-(6-氧代哌啶-3-基... 172913-96-1 |
| 文献:Langlois, Nicole Tetrahedron Letters, 2002 , vol. 43, # 52 p. 9531 - 9533 |
|
~%
(S)-(6-氧代哌啶-3-基... 172913-96-1 |
| 文献:Langlois, Nicole Tetrahedron Letters, 2002 , vol. 43, # 52 p. 9531 - 9533 |
| (S)-(6-氧代哌啶-3-基)氨基甲酸叔丁酯上游产品 6 | |
|---|---|
| (S)-(6-氧代哌啶-3-基)氨基甲酸叔丁酯下游产品 1 | |
| L-5-methylhydantoin |
| 5-methylhydantoin |
| Prestwick_215 |